CY1117637T1 - HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES - Google Patents

HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES

Info

Publication number
CY1117637T1
CY1117637T1 CY20161100402T CY161100402T CY1117637T1 CY 1117637 T1 CY1117637 T1 CY 1117637T1 CY 20161100402 T CY20161100402 T CY 20161100402T CY 161100402 T CY161100402 T CY 161100402T CY 1117637 T1 CY1117637 T1 CY 1117637T1
Authority
CY
Cyprus
Prior art keywords
b7rp1
antibodies
function
human anti
human
Prior art date
Application number
CY20161100402T
Other languages
Greek (el)
Inventor
Gerald Siu
Wenyan Shen
Steven Kiyoshi Yoshinaga
Haichun Huang
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06787719.1A external-priority patent/EP1915398B1/en
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of CY1117637T1 publication Critical patent/CY1117637T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η εφεύρεση αυτή παρέχει αντισώματα που αλληλεπιδρούν με ανθρώπινη Β7 σχετική πρωτεΐνη-1 (B7RP1) ή συνδέονται προς ανθρώπινη Β7 σχετική πρωτεΐνη-1 (B7RP1) και αντισώματα που συνδέονται προς την λειτουργία της B7RP1 και με τον τρόπο αυτό εξουδετερώνουν την λειτουργία της B7RP1. Η εφεύρεση παρέχει επίσης φαρμακευτικές συνθέσεις των εν λόγω αντισωμάτων και μεθόδους για εξουδετέρωση λειτουργίας B7RP1 και ιδιαιτέρως για θεραπεία ανοσοδιαταραχών (π.χ., ακατάλληλης ανοσοαπόκρισης) με χορήγηση φαρμακευτικώς αποτελεσματικής ποσότητας των αντι-B7RP1 αντισωμάτων. Επίσης παρέχονται μέθοδοι για ανίχνευση ποσότητας B7RP1 σε ένα δείγμα χρησιμοποιώντας αντι-B7RP1 αντισώματα.This invention provides antibodies that interact with human B7 related protein-1 (B7RP1) or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to the function of B7RP1 and thereby neutralize the function of B7RP1. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and in particular for the treatment of immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods for detecting a quantity of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.

CY20161100402T 2005-07-18 2016-05-12 HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES CY1117637T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70026505A 2005-07-18 2005-07-18
EP06787719.1A EP1915398B1 (en) 2005-07-18 2006-07-18 Human anti-b7rp1 neutralizing antibodies

Publications (1)

Publication Number Publication Date
CY1117637T1 true CY1117637T1 (en) 2017-04-26

Family

ID=58606658

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100402T CY1117637T1 (en) 2005-07-18 2016-05-12 HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES

Country Status (1)

Country Link
CY (1) CY1117637T1 (en)

Similar Documents

Publication Publication Date Title
SG164369A1 (en) Human anti-b7rp1 neutralizing antibodies
CY1113167T1 (en) HUMAN ANTI-NGF CONTROLLED ANTIBODIES AS NGF pathway-selective inhibitors
CY1119618T1 (en) UNIONS AND COMPOSITIONS AS REGULATORY PARTS OF TLR ACTIVITY
CY1121162T1 (en) M-CSF-SPECIAL MONOCLONIC ANTIBODY AND ITS USE
CY1120297T1 (en) ANDROGEN RECEPTORS ADJUSTERS AND USES
CY1123030T1 (en) MATERIALS AND METHODS FOR TREATING OR PREVENTING HER-3 RELATED DISEASES
CY1120665T1 (en) HUMANIZED ANTI-CXCR5 ANTIBODIES, DERIVATIVES OF THEM AND THEIR USES
CY1116230T1 (en) BINDING-NOTCH FACTORS AND COMPETITORS AND METHODS OF USE THEREOF
CY1118943T1 (en) ANTI-PD-L1 ANTIBODIES AND USE OF THESE TO ENHANCE T-CELL FUNCTIONING
CY1118660T1 (en) COMPOSITIONS AND METHODS FOR EYE DISORDER TREATMENT
DE602005020474D1 (en) Antibodies to phosphorylcholine conjugates
CY1118377T1 (en) SYK IMIDAZOPYRAZIN INHIBITIONS
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
CY1113640T1 (en) METHODS FOR TREATMENT OF Rheumatoid Arthritis
EA200800952A1 (en) CONJUGATES ANTIBODY-DRUG AND METHODS OF APPLICATION
CY1112751T1 (en) METHOD OF FORMING THE PROTEIN COGNITION WITH GPR119 RECEPTORS AND SELECTED COMPOUNDS
CY1115871T1 (en) METHODS FOR TREATMENT OF URINARY ARTHRITIS
CY1112739T1 (en) ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE
ECSP088804A (en) ANTAGONISTS OF THE AMIDA PIRIDIL OF THE TYPE T CALCIUM CHANNELS
CU24644B1 (en) ANTIBODY-DRUG CONJUGATES FOR ABLATION OF HEMATOPOIETIC STEM CELLS
CR10099A (en) IMMUNOGLOBULINS DIRECTED AGAINST NOGO
ATE476193T1 (en) IMMUNO-STIMULATORY PROCEDURE
EA201070636A1 (en) INHIBITION OF THE PROTECTOR PROTEIN, STIMULATING MACROPHAGE (RON), AND METHODS OF ITS TREATMENT
CY1110190T1 (en) Piperazinyl derivative useful in the treatment of diseases mediated by the GPR38 receptor
CY1116802T1 (en) Heterocyclic compounds